Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics

References

• Zhong J, Shi G. Editorial: regulation of inflammation in chronic disease. Front Immunol. 2019;10:737. doi:10.3389/fimmu.2019.00737
   PubMed Web of Science ®Google Scholar
• Alessandri AL, Sousa LP, Lucas CD, et al. Resolution of inflammation: mechanisms and opportunity for drug development. Pharmacol Ther. 2013;139(2):189–212. doi:10.1016/j.pharmthera.2013.04.006
   PubMed Web of Science ®Google Scholar
• Sugimoto MA, Sousa LP, Pinho V, et al. Resolution of inflammation: what controls its onset?. Front Immunol. 2016;7:160. doi:10.3389/fimmu.2016.00160
   PubMed Web of Science ®Google Scholar
• Germolec DR, Shipkowski KA, Frawley RP, Evans E, et al. Markers of inflammation. Methods Mol Biol. 2018;1803:57–79. doi:10.1007/978-1-4939-8549-4_5
   PubMedGoogle Scholar
• Dhingra AK, Chopra B, Dass R, et al. An update on anti-inflammatory compounds: a review. Antiinflamm Antiallergy Agents Med Chem. 2015;14(2):81–97. doi:10.2174/1871523014666150514102027
   PubMedGoogle Scholar
• Patil KR, Mahajan UB, Unger BS, et al. Animal models of inflammation for screening of anti-inflammatory drugs: implications for the discovery and development of phytopharmaceuticals. Int J Mol Sci. 2019;20(18):4367. doi:10.3390/ijms20184367
   PubMed Web of Science ®Google Scholar
• Menshikov M, Zubkova E, Stafeev I, et al. Autophagy, mesenchymal stem cell differentiation, and secretion. Biomedicines. 2021;9(9):1178. doi:10.3390/biomedicines9091178
   PubMed Web of Science ®Google Scholar
• Pires AO, Mendes-Pinheiro B, Teixeira FG, et al. Unveiling the differences of secretome of human bone marrow mesenchymal stem cells, adipose tissue-derived stem cells, and human umbilical cord perivascular cells: a proteomic analysis. Stem Cells Dev. 2016;25(14):1073–1083. doi:10.1089/scd.2016.0048
   PubMed Web of Science ®Google Scholar
• Guadix JA, Zugaza JL, Gálvez-Martín P, et al. Characteristics, applications and prospects of mesenchymal stem cells in cell therapy. Med Clin (Barc). 2017;148(9):408–414. doi:10.1016/j.medcli.2016.11.033
   PubMed Web of Science ®Google Scholar
• Wei X, Yang X, Han Z-P, et al. Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin. 2013;34(6):747–754. doi:10.1038/aps.2013.50
   PubMed Web of Science ®Google Scholar
• Shi Y, Wang Y, Li Q, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14(8):493–507. doi:10.1038/s41581-018-0023-5
   PubMed Web of Science ®Google Scholar
• Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells. 2017;35(4):851–858. doi:10.1002/stem.2575
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang Y, Kong Y, et al. Exosomes derived from mesenchymal stem cells modulate miR-126 to ameliorate hyperglycemia-induced retinal inflammation via targeting HMGB1. Invest Ophthalmol Vis Sci. 2019;60(1):294–303. doi:10.1167/iovs.18-25617
   PubMed Web of Science ®Google Scholar
• Wu P, Zhang B, Shi H, et al. MSC-exosome: a novel cell-free therapy for cutaneous regeneration. Cytotherapy. 2018;20(3):291–301. doi:10.1016/j.jcyt.2017.11.002
   PubMed Web of Science ®Google Scholar
• Stanko P, Kaiserova K, Altanerova V, et al. Comparison of human mesenchymal stem cells derived from dental pulp, bone marrow, adipose tissue, and umbilical cord tissue by gene expression. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(3):373–377. doi:10.5507/bp.2013.078
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–317. doi:10.1080/14653240600855905
   PubMed Web of Science ®Google Scholar
• Heo JS, Choi Y, Kim H-S, et al. Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue. Int J Mol Med. 2016;37(1):115–125. doi:10.3892/ijmm.2015.2413
   PubMed Web of Science ®Google Scholar
• Almalki SG, Agrawal DK. Key transcription factors in the differentiation of mesenchymal stem cells. Differentiation. 2016;92(1–2):41–51. doi:10.1016/j.diff.2016.02.005
   PubMed Web of Science ®Google Scholar
• Kobolak J, Dinnyes A, Memic A, et al. Mesenchymal stem cells: identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche. Methods. 2016;99:62–68. doi:10.1016/j.ymeth.2015.09.016
   PubMed Web of Science ®Google Scholar
• Brown C, McKee C, Bakshi S, et al. Mesenchymal stem cells: cell therapy and regeneration potential. J Tissue Eng Regen Med. 2019;13(9):1738–1755. doi:10.1002/term.2914
   PubMed Web of Science ®Google Scholar
• Uder C, Brückner S, Winkler S, et al. Mammalian MSC from selected species: features and applications. Cytometry A. 2018;93(1):32–49. doi:10.1002/cyto.a.23239
   PubMed Web of Science ®Google Scholar
• Kalluri R, Lebleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478). doi:10.1126/science.aau6977
   PubMed Web of Science ®Google Scholar
• Yu X, Odenthal M, Fries JW, et al. Exosomes as miRNA carriers: formation-function-future. Int J Mol Sci. 2016;17(12):2028. doi:10.3390/ijms17122028
   PubMed Web of Science ®Google Scholar
• Sun Z, Shi K, Yang S, et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer. 2018;17(1):147. doi:10.1186/s12943-018-0897-7
   PubMed Web of Science ®Google Scholar
• Liu H, Chen Y, Yin G, et al. Therapeutic prospects of MicroRNAs carried by mesenchymal stem cells-derived extracellular vesicles in autoimmune diseases. Life Sci. 2021;277:119458. doi:10.1016/j.lfs.2021.119458
   PubMed Web of Science ®Google Scholar
• Hamidzadeh K, Christensen SM, Dalby E, et al. Macrophages and the recovery from acute and chronic inflammation. Annu Rev Physiol. 2017;79(1):567–592. doi:10.1146/annurev-physiol-022516-034348
   PubMed Web of Science ®Google Scholar
• Song W-J, Li Q, Ryu M-O, et al. TSG-6 released from intraperitoneally injected canine adipose tissue-derived mesenchymal stem cells ameliorate inflammatory bowel disease by inducing M2 macrophage switch in mice. Stem Cell Res Ther. 2018;9(1):91. doi:10.1186/s13287-018-0841-1
   PubMed Web of Science ®Google Scholar
• Geng Y, Zhang L, Fu B, et al. Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages. Stem Cell Res Ther. 2014;5(3):80. doi:10.1186/scrt469
   PubMed Web of Science ®Google Scholar
• Bacskai I, Mázló A, Kis-Tóth K, et al. Mesenchymal stromal cell-like cells set the balance of stimulatory and inhibitory signals in monocyte-derived dendritic cells. Stem Cells Dev. 2015;24(15):1805–1816. doi:10.1089/scd.2014.0509
   PubMed Web of Science ®Google Scholar
• Lu Z, Chang W, Meng S, et al. Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury. Stem Cell Res Ther. 2019;10(1):372. doi:10.1186/s13287-019-1488-2
   PubMed Web of Science ®Google Scholar
• Ðokić JM, Z. Tomic S, J. Colic M, et al. Cross-talk between mesenchymal stem/stromal cells and dendritic cells. Curr Stem Cell Res Ther. 2016;11(1):51–65. doi:10.2174/1574888X10666150904114035
   PubMed Web of Science ®Google Scholar
• Cui R, Rekasi H, Hepner-Schefczyk M, et al. Human mesenchymal stromal/stem cells acquire immunostimulatory capacity upon cross-talk with natural killer cells and might improve the NK cell function of immunocompromised patients. Stem Cell Res Ther. 2016;7(1):88. doi:10.1186/s13287-016-0353-9
   PubMed Web of Science ®Google Scholar
• Markov A, Thangavelu L, Aravindhan S, et al. Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders. Stem Cell Res Ther. 2021;12(1):192. doi:10.1186/s13287-021-02265-1
   PubMed Web of Science ®Google Scholar
• Song J-Y, Kang HJ, Ju HM, et al. Umbilical cord-derived mesenchymal stem cell extracts ameliorate atopic dermatitis in mice by reducing the T cell responses. Sci Rep. 2019;9(1):6623. doi:10.1038/s41598-019-42964-7
   PubMed Web of Science ®Google Scholar
• Ma Y, Wang Z, Zhang A, et al. Human placenta-derived mesenchymal stem cells ameliorate GVHD by modulating Th17/Tr1 balance via expression of PD-L2. Life Sci. 2018;214:98–105. doi:10.1016/j.lfs.2018.10.061
   PubMed Web of Science ®Google Scholar
• Euler M, Hoffmann MH. The double-edged role of neutrophil extracellular traps in inflammation. Biochem Soc Trans. 2019;47(6):1921–1930. doi:10.1042/bst20190629
   PubMed Web of Science ®Google Scholar
• Liu S, Su X, Pan P, et al. Neutrophil extracellular traps are indirectly triggered by lipopolysaccharide and contribute to acute lung injury. Sci Rep. 2016;6(1):37252. doi:10.1038/srep37252
   PubMed Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. doi:10.1016/s0140-6736(20)30628-0
   PubMed Web of Science ®Google Scholar
• Ye Q, Wang B, Mao J, et al. The pathogenesis and treatment of the “Cytokine Storm” in COVID-19. J Infect. 2020;80(6):607–613. doi:10.1016/j.jinf.2020.03.037
   PubMed Web of Science ®Google Scholar
• Chen J, Shao Y, Xu G, et al. Bone marrow-derived mesenchymal stem cells attenuate phosgene-induced acute lung injury in rats. Inhal Toxicol. 2015;27(5):254–261. doi:10.3109/08958378.2015.1037029
   PubMed Web of Science ®Google Scholar
• Nitzsche F, Müller C, Lukomska B, et al. Concise review: MSC adhesion cascade-insights into homing and transendothelial migration. Stem Cells. 2017;35(6):1446–1460. doi:10.1002/stem.2614
   PubMed Web of Science ®Google Scholar
• Ullah M, Liu DD, Thakor AS, et al. Mesenchymal stromal cell homing: mechanisms and strategies for improvement. iScience. 2019;15:421–438. doi:10.1016/j.isci.2019.05.004
   PubMed Web of Science ®Google Scholar
• Liesveld JL, Sharma N, Aljitawi OS, et al. Stem cell homing: from physiology to therapeutics. Stem Cells. 2020;38(10):1241–1253. doi:10.1002/stem.3242
   PubMed Web of Science ®Google Scholar
• Leibacher J, Henschler R. Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells. Stem Cell Res Ther. 2016;7:7. doi:10.1186/s13287-015-0271-2
   PubMed Web of Science ®Google Scholar
• Szydlak R. Biological, chemical and mechanical factors regulating migration and homing of mesenchymal stem cells. World J Stem Cells. 2021;13(6):619–631. doi:10.4252/wjsc.v13.i6.619
   PubMed Web of Science ®Google Scholar
• Jiang Q, Huang K, Lu F, et al. Modifying strategies for SDF-1/CXCR4 interaction during mesenchymal stem cell transplantation. Gen Thorac Cardiovasc Surg. 2021;70:1–10. doi:10.1007/s11748-021-01696-0
   PubMed Web of Science ®Google Scholar
• Si XY, Li -J-J, Yao T, et al. Transforming growth factor-β1 in the microenvironment of ischemia reperfusion-injured kidney enhances the chemotaxis of mesenchymal stem cells to stromal cell-derived factor-1 through upregulation of surface chemokine (C-X-C motif) receptor 4. Mol Med Rep. 2014;9(5):1794–1798. doi:10.3892/mmr.2014.1989
   PubMed Web of Science ®Google Scholar
• Yu X, Lu C, Liu H, et al. Hypoxic preconditioning with cobalt of bone marrow mesenchymal stem cells improves cell migration and enhances therapy for treatment of ischemic acute kidney injury. PLoS One. 2013;8(5):e62703. doi:10.1371/journal.pone.0062703
   PubMed Web of Science ®Google Scholar
• Li Q, Gao Z, Chen Y, et al. The role of mitochondria in osteogenic, adipogenic and chondrogenic differentiation of mesenchymal stem cells. Protein Cell. 2017;8(6):439–445. doi:10.1007/s13238-017-0385-7
   PubMed Web of Science ®Google Scholar
• Atashi F, Modarressi A, Pepper MS, et al. The role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation: a review. Stem Cells Dev. 2015;24(10):1150–1163. doi:10.1089/scd.2014.0484
   PubMed Web of Science ®Google Scholar
• Han Y, Li X, Zhang Y, et al. Mesenchymal stem cells for regenerative medicine. Cells. 2019;8(8):886. doi:10.3390/cells8080886
   PubMed Web of Science ®Google Scholar
• Baglio SR, Rooijers K, Koppers-Lalic D, et al. Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res Ther. 2015;6(1):127. doi:10.1186/s13287-015-0116-z
   PubMed Web of Science ®Google Scholar
• Meng Y, Eirin A, Zhu X-Y, et al. The metabolic syndrome alters the miRNA signature of porcine adipose tissue-derived mesenchymal stem cells. Cytometry A. 2018;93(1):93–103. doi:10.1002/cyto.a.23165
   PubMed Web of Science ®Google Scholar
• Li Y, Meng Y, Zhu X, et al. Metabolic syndrome is associated with altered mRNA and miRNA content in human circulating extracellular vesicles. Front Endocrinol (Lausanne). 2021;12:687586. doi:10.3389/fendo.2021.687586
   PubMed Web of Science ®Google Scholar
• Levey AS, James MT. Acute kidney injury. Ann Intern Med. 2017;167(9):ITC66–ITC80. doi:10.7326/AITC201711070
   PubMed Web of Science ®Google Scholar
• Schneider AG, Bagshaw SM. Effects of renal replacement therapy on renal recovery after acute kidney injury. Nephron Clin Pract. 2014;127(1–4):35–41. doi:10.1159/000363671
   PubMedGoogle Scholar
• De Almeida DC, Donizetti-Oliveira C, Barbosa-Costa P, et al. In search of mechanisms associated with mesenchymal stem cell-based therapies for acute kidney injury. Clin Biochem Rev. 2013;34(3):131–144.
   PubMedGoogle Scholar
• Yu SM-W, Bonventre JV. Acute kidney injury and maladaptive tubular repair leading to renal fibrosis. Curr Opin Nephrol Hypertens. 2020;29(3):310–318. doi:10.1097/mnh.0000000000000605
   PubMed Web of Science ®Google Scholar
• Zhang R, Yin L, Zhang B, et al. Resveratrol improves human umbilical cord-derived mesenchymal stem cells repair for cisplatin-induced acute kidney injury. Cell Death Dis. 2018;9(10):965. doi:10.1038/s41419-018-0959-1
   PubMed Web of Science ®Google Scholar
• Machiguchi T, Nakamura T. Nephron generation in kidney cortices through injection of pretreated mesenchymal stem cell-differentiated tubular epithelial cells. Biochem Biophys Res Commun. 2019;518(1):141–147. doi:10.1016/j.bbrc.2019.08.022
   PubMed Web of Science ®Google Scholar
• Zhao L, Hu C, Zhang P, et al. Mesenchymal stem cell therapy targeting mitochondrial dysfunction in acute kidney injury. J Transl Med. 2019;17(1):142. doi:10.1186/s12967-019-1893-4
   PubMed Web of Science ®Google Scholar
• Bhargava P, Schnellmann RG. Mitochondrial energetics in the kidney. Nat Rev Nephrol. 2017;13(10):629–646. doi:10.1038/nrneph.2017.107
   PubMed Web of Science ®Google Scholar
• Perico L, Morigi M, Rota C, et al. Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial function. Nat Commun. 2017;8(1):983. doi:10.1038/s41467-017-00937-2
   PubMed Web of Science ®Google Scholar
• Peng X, Xu H, Zhou Y, et al. Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury. Exp Biol Med (Maywood). 2013;238(8):960–970. doi:10.1177/1535370213497176
   PubMed Web of Science ®Google Scholar
• Treiber T, Treiber N, Meister G, et al. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol. 2019;20(1):5–20. doi:10.1038/s41580-018-0059-1
   PubMed Web of Science ®Google Scholar
• Collino F, Bruno S, Incarnato D, et al. AKI recovery induced by mesenchymal stromal cell-derived extracellular vesicles carrying MicroRNAs. J Am Soc Nephrol. 2015;26(10):2349–2360. doi:10.1681/asn.2014070710
   PubMed Web of Science ®Google Scholar
• Wang C, Zhu G, He W, et al. BMSCs protect against renal ischemia-reperfusion injury by secreting exosomes loaded with miR-199a-5p that target BIP to inhibit endoplasmic reticulum stress at the very early reperfusion stages. FASEB j. 2019;33(4):5440–5456. doi:10.1096/fj.201801821R
   PubMed Web of Science ®Google Scholar
• Zhu G, Pei L, Lin F, et al. Exosomes from human-bone-marrow-derived mesenchymal stem cells protect against renal ischemia/reperfusion injury via transferring miR-199a-3p. J Cell Physiol. 2019;234(12):23736–23749. doi:10.1002/jcp.28941
   PubMed Web of Science ®Google Scholar
• Cao J-Y, Wang B, Tang -T-T, et al. Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury. Theranostics. 2021;11(11):5248–5266. doi:10.7150/thno.54550
   PubMed Web of Science ®Google Scholar
• Galipeau J, Sensébé L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018;22(6):824–833. doi:10.1016/j.stem.2018.05.004
   PubMed Web of Science ®Google Scholar
• Zhao L, Hu C, Zhang P, et al. Melatonin preconditioning is an effective strategy for mesenchymal stem cell-based therapy for kidney disease. J Cell Mol Med. 2020;24(1):25–33. doi:10.1111/jcmm.14769
   PubMed Web of Science ®Google Scholar
• Cai J, Yu X, Zhang B, et al. Atorvastatin improves survival of implanted stem cells in a rat model of renal ischemia-reperfusion injury. Am J Nephrol. 2014;39(6):466–475. doi:10.1159/000362623
   PubMed Web of Science ®Google Scholar
• Burks SR, Nguyen BA, Tebebi PA, et al. Pulsed focused ultrasound pretreatment improves mesenchymal stromal cell efficacy in preventing and rescuing established acute kidney injury in mice. Stem Cells. 2015;33(4):1241–1253. doi:10.1002/stem.1965
   PubMed Web of Science ®Google Scholar
• Xu Y, Shi T, Xu A, et al. 3D spheroid culture enhances survival and therapeutic capacities of MSC s injected into ischemic kidney. J Cell Mol Med. 2016;20(7):1203–1213. doi:10.1111/jcmm.12651
   PubMed Web of Science ®Google Scholar
• Wang H, Shang Y, Chen X, et al. Delivery of MSCs with a Hybrid β-sheet peptide hydrogel consisting IGF-1C domain and D-form peptide for acute kidney injury therapy. Int J Nanomedicine. 2020;15:4311–4324. doi:10.2147/ijn.S254635
   PubMed Web of Science ®Google Scholar
• Gao J, Liu R, Wu J, et al. The use of chitosan based hydrogel for enhancing the therapeutic benefits of adipose-derived MSCs for acute kidney injury. Biomaterials. 2012;33(14):3673–3681. doi:10.1016/j.biomaterials.2012.01.061
   PubMed Web of Science ®Google Scholar
• Liu Y, Fang J, Mareschi K. Mesenchymal stem cells as therapeutic agents and novel carriers for the delivery of candidate genes in acute kidney injury. Stem Cells Int. 2020;2020:8875554. doi:10.1155/2020/8875554
   PubMed Web of Science ®Google Scholar
• Liu N, Tian J, Cheng J, et al. Migration of CXCR4 gene-modified bone marrow-derived mesenchymal stem cells to the acute injured kidney. J Cell Biochem. 2013;114(12):2677–2689. doi:10.1002/jcb.24615
   PubMed Web of Science ®Google Scholar
• Zhaleh F, Amiri F, Mohammadzadeh-Vardin M, et al. Nuclear factor erythroid-2 related factor 2 overexpressed mesenchymal stem cells transplantation, improves renal function, decreases injuries markers and increases repair markers in glycerol-induced Acute kidney injury rats.. Iran J Basic Med Sci. 2016;19(3):323–329.
   PubMed Web of Science ®Google Scholar
• Mashel TV, Tarakanchikova YV, Muslimov AR, et al. Overcoming the delivery problem for therapeutic genome editing: current status and perspective of non-viral methods. Biomaterials. 2020;258:120282. doi:10.1016/j.biomaterials.2020.120282
   PubMed Web of Science ®Google Scholar
• Wang W, Xu X, Li Z, et al. Genetic engineering of mesenchymal stem cells by non-viral gene delivery. Clin Hemorheol Microcirc. 2014;58(1):19–48. doi:10.3233/ch-141883
   PubMed Web of Science ®Google Scholar
• Cheng K, Rai P, Plagov A, et al. Transplantation of bone marrow-derived MSCs improves cisplatinum-induced renal injury through paracrine mechanisms. Exp Mol Pathol. 2013;94(3):466–473. doi:10.1016/j.yexmp.2013.03.002
   PubMed Web of Science ®Google Scholar
• Zhao L, Hu C, Zhang P, et al. Preconditioning strategies for improving the survival rate and paracrine ability of mesenchymal stem cells in acute kidney injury. J Cell Mol Med. 2019;23(2):720–730. doi:10.1111/jcmm.14035
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu L, Huo Y, et al. Hypoxia-pretreated human MSCs attenuate acute kidney injury through enhanced angiogenic and antioxidative capacities. Biomed Res Int. 2014;2014:462472. doi:10.1155/2014/462472
   PubMed Web of Science ®Google Scholar
• Bai M, Zhang L, Fu B, et al. IL-17A improves the efficacy of mesenchymal stem cells in ischemic-reperfusion renal injury by increasing Treg percentages by the COX-2/PGE2 pathway. Kidney Int. 2018;93(4):814–825. doi:10.1016/j.kint.2017.08.030
   PubMed Web of Science ®Google Scholar
• Roudkenar MH, Halabian R, Tehrani HA, et al. Lipocalin 2 enhances mesenchymal stem cell-based cell therapy in acute kidney injury rat model. Cytotechnology. 2018;70(1):103–117. doi:10.1007/s10616-017-0107-2
   PubMed Web of Science ®Google Scholar
• Zhang C, Shang Y, Chen X, et al. Supramolecular nanofibers containing arginine-glycine-aspartate (RGD) peptides boost therapeutic efficacy of extracellular vesicles in kidney repair. ACS Nano. 2020;14(9):12133–12147. doi:10.1021/acsnano.0c05681
   PubMed Web of Science ®Google Scholar
• Tögel FE, Westenfelder C. Kidney protection and regeneration following acute injury: progress through stem cell therapy. Am J Kidney Dis. 2012;60(6):1012–1022. doi:10.1053/j.ajkd.2012.08.034
   PubMed Web of Science ®Google Scholar
• Swaminathan M, Stafford-Smith M, Chertow GM, et al. Allogeneic mesenchymal stem cells for treatment of AKI after cardiac surgery. J Am Soc Nephrol. 2018;29(1):260–267. doi:10.1681/asn.2016101150
   PubMed Web of Science ®Google Scholar
• Peck TJ, Hibbert KA. Recent advances in the understanding and management of ARDS. F1000Res. 2019;8:1959. doi:10.12688/f1000research.20411.1
   Google Scholar
• Salian VS, Wright JA, Vedell PT, et al. COVID-19 transmission, current treatment, and future therapeutic strategies. Mol Pharm. 2021;18(3):754–771. doi:10.1021/acs.molpharmaceut.0c00608
   PubMed Web of Science ®Google Scholar
• Hu B, Huang S, Yin L, et al. The cytokine storm and COVID-19. J Med Virol. 2021;93(1):250–256. doi:10.1002/jmv.26232
   PubMed Web of Science ®Google Scholar
• Butt Y, Kurdowska A, Allen TC, et al. Acute lung injury: a clinical and molecular review. Arch Pathol Lab Med. 2016;140(4):345–350. doi:10.5858/arpa.2015-0519-RA
   PubMed Web of Science ®Google Scholar
• Mokra D, Mikolka P, Kosutova P, Mokry J, et al. Corticosteroids in acute lung injury: the dilemma continues. Int J Mol Sci. 2019;20(19):4765. doi:10.3390/ijms20194765
   PubMed Web of Science ®Google Scholar
• Shi X, Mao J, Liu Y, et al. Pulp stem cells derived from human permanent and deciduous teeth: biological characteristics and therapeutic applications. Stem Cells Transl Med. 2020;9(4):445–464. doi:10.1002/sctm.19-0398
   PubMed Web of Science ®Google Scholar
• Higginbotham K, Tian Y, Gawlak G, et al. Hepatocyte growth factor triggers distinct mechanisms of Asef and Tiam1 activation to induce endothelial barrier enhancement. Cell Signal. 2014;26(11):2306–2316. doi:10.1016/j.cellsig.2014.07.032
   PubMed Web of Science ®Google Scholar
• Chen J, Li C, Gao X, et al. Keratinocyte growth factor gene delivery via mesenchymal stem cells protects against lipopolysaccharide-induced acute lung injury in mice. PLoS One. 2013;8(12):e83303. doi:10.1371/journal.pone.0083303
   PubMed Web of Science ®Google Scholar
• Li JW, Wu X. Mesenchymal stem cells ameliorate LPS-induced acute lung injury through KGF promoting alveolar fluid clearance of alveolar type II cells. Eur Rev Med Pharmacol Sci. 2015;19(13):2368–2378.
   PubMed Web of Science ®Google Scholar
• Monsel A, Zhu Y-G, Gennai S, et al. Therapeutic effects of human mesenchymal stem cell-derived microvesicles in severe pneumonia in mice. Am J Respir Crit Care Med. 2015;192(3):324–336. doi:10.1164/rccm.201410-1765OC
   PubMed Web of Science ®Google Scholar
• Yi X, Wei X, Lv H, et al. Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3. Exp Cell Res. 2019;383(2):111454. doi:10.1016/j.yexcr.2019.05.035
   PubMed Web of Science ®Google Scholar
• Li JW, Wei L, Han Z, Chen Z, et al. Mesenchymal stromal cells-derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p. Eur J Pharmacol. 2019;852:68–76. doi:10.1016/j.ejphar.2019.01.022
   PubMed Web of Science ®Google Scholar
• Liu JS, Du J, Cheng X, et al. Exosomal miR-451 from human umbilical cord mesenchymal stem cells attenuates burn-induced acute lung injury. J Chin Med Assoc. 2019;82(12):895–901. doi:10.1097/jcma.0000000000000189
   PubMed Web of Science ®Google Scholar
• Zhu YG, Hao Q, Monsel A, et al. Adult stem cells for acute lung injury: remaining questions and concerns. Respirology. 2013;18(5):744–756. doi:10.1111/resp.12093
   PubMed Web of Science ®Google Scholar
• Zheng G, Huang L, Tong H, et al. Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study. Respir Res. 2014;15(1):39. doi:10.1186/1465-9921-15-39
   PubMed Web of Science ®Google Scholar
• Wilson JG, Liu KD, Zhuo H, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med. 2015;3(1):24–32. doi:10.1016/s2213-2600(14)70291-7
   PubMed Web of Science ®Google Scholar
• Matthay MA, Calfee CS, Zhuo H, et al. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Respir Med. 2019;7(2):154–162. doi:10.1016/s2213-2600(18)30418-1
   PubMed Web of Science ®Google Scholar
• Zhou Z, You Z. Mesenchymal stem cells alleviate LPS-induced acute lung injury in mice by MiR-142a-5p-controlled pulmonary endothelial cell autophagy. Cell Physiol Biochem. 2016;38(1):258–266. doi:10.1159/000438627
   PubMed Web of Science ®Google Scholar
• Leng Z, Zhu R, Hou W, et al. Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with COVID-19 Pneumonia. Aging Dis. 2020;11(2):216–228. doi:10.14336/ad.2020.0228
   PubMed Web of Science ®Google Scholar
• Liang B, Chen J, Li T, et al. Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: a case report. Medicine. 2020;99(31):e21429. doi:10.1097/md.0000000000021429
   PubMed Web of Science ®Google Scholar
• Sengupta V, Sengupta S, Lazo A, et al. Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19. Stem Cells Dev. 2020;29(12):747–754. doi:10.1089/scd.2020.0080
   PubMed Web of Science ®Google Scholar
• Yousefi Dehbidi M, Goodarzi N, Azhdari MH, et al. Mesenchymal stem cells and their derived exosomes to combat Covid–19. Rev Med Virol. 2022;32(2):e2281. doi:10.1002/rmv.2281
   PubMed Web of Science ®Google Scholar
• Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med. 2020;382(24):2327–2336. doi:10.1056/NEJMoa2007016
   PubMed Web of Science ®Google Scholar
• Arden NK, Leyland KM. Osteoarthritis year 2013 in review: clinical. Osteoarthritis Cartilage. 2013;21(10):1409–1413. doi:10.1016/j.joca.2013.06.021
   PubMed Web of Science ®Google Scholar
• Kim SJ, Shetty AA, Kurian NM, et al. Articular cartilage repair using autologous collagen-induced chondrogenesis (ACIC): a pragmatic and cost-effective enhancement of a traditional technique. Knee Surg Sports Traumatol Arthrosc. 2020;28(8):2598–2603. doi:10.1007/s00167-020-05884-y
   PubMed Web of Science ®Google Scholar
• Kong L, Zheng L-Z, Qin L, et al. Role of mesenchymal stem cells in osteoarthritis treatment. J Orthop Translat. 2017;9:89–103. doi:10.1016/j.jot.2017.03.006
   PubMed Web of Science ®Google Scholar
• Cush JJ. Rheumatoid arthritis: early diagnosis and treatment. Med Clin North Am. 2021;105(2):355–365. doi:10.1016/j.mcna.2020.10.006
   PubMed Web of Science ®Google Scholar
• Scherer HU, Häupl T, Burmester GR, et al. The etiology of rheumatoid arthritis. J Autoimmun. 2020;110:102400. doi:10.1016/j.jaut.2019.102400
   PubMed Web of Science ®Google Scholar
• Lin YJ, Anzaghe M, Schülke S, et al. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells. 2020;9(4). doi:10.3390/cells9040880
   Web of Science ®Google Scholar
• Singh JA, Saag KG, Bridges SL, et al. 2015 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 2016;68(1):1–25. doi:10.1002/acr.22783
   PubMed Web of Science ®Google Scholar
• Beasley J. Osteoarthritis and rheumatoid arthritis: conservative therapeutic management. J Hand Ther. 2012;25(2):163–71; quiz 172. doi:10.1016/j.jht.2011.11.001
   PubMed Web of Science ®Google Scholar
• Guo W-Z, Di H, Chu G-H, et al. Comparative analysis of conventional and biological treatment in healing of bone disease. Saudi J Biol Sci. 2018;25(1):162–166. doi:10.1016/j.sjbs.2017.02.003
   PubMed Web of Science ®Google Scholar
• Ter Huurne M, Schelbergen R, Blattes R, et al. Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis. Arthritis Rheum. 2012;64(11):3604–3613. doi:10.1002/art.34626
   PubMed Web of Science ®Google Scholar
• Jiang X, Huang B, Yang H, et al. TGF-β1 is involved in Vitamin D-induced chondrogenic differentiation of bone marrow-derived mesenchymal stem cells by regulating the ERK/JNK pathway. Cell Physiol Biochem. 2017;42(6):2230–2241. doi:10.1159/000479997
   PubMedGoogle Scholar
• Lu Z, Lei D, Jiang T, et al. Nerve growth factor from Chinese cobra venom stimulates chondrogenic differentiation of mesenchymal stem cells. Cell Death Dis. 2017;8(5):e2801. doi:10.1038/cddis.2017.208
   PubMed Web of Science ®Google Scholar
• Mahboudi H, Kazemi B, Soleimani M, et al. Enhanced chondrogenesis of human bone marrow mesenchymal Stem Cell (BMSC) on nanofiber-based polyethersulfone (PES) scaffold. Gene. 2018;643:98–106. doi:10.1016/j.gene.2017.11.073
   PubMed Web of Science ®Google Scholar
• Wang R, Xu B, Xu H, et al. TGF-β1 promoted chondrocyte proliferation by regulating Sp1 through MSC-exosomes derived miR-135b. Cell Cycle. 2018;17(24):2756–2765. doi:10.1080/15384101.2018.1556063
   PubMed Web of Science ®Google Scholar
• Chen Z, Wang H, Xia Y, et al. Therapeutic potential of mesenchymal cell-derived miRNA-150-5p-expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF. J Immunol. 2018;201(8):2472–2482. doi:10.4049/jimmunol.1800304
   PubMed Web of Science ®Google Scholar
• Zhou M, Lozano N, Wychowaniec JK, et al. Graphene oxide: a growth factor delivery carrier to enhance chondrogenic differentiation of human mesenchymal stem cells in 3D hydrogels. Acta Biomater. 2019;96:271–280. doi:10.1016/j.actbio.2019.07.027
   PubMed Web of Science ®Google Scholar
• Ra JC, Kang SK, Shin IS, et al. Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Transl Med. 2011;9(1):181. doi:10.1186/1479-5876-9-181
   PubMed Web of Science ®Google Scholar
• Wang L, Huang S, Li S, et al. Efficacy and safety of umbilical cord mesenchymal stem cell therapy for rheumatoid arthritis patients: a prospective Phase I/II study. Drug Des Devel Ther. 2019;13:4331–4340. doi:10.2147/dddt.S225613
   PubMed Web of Science ®Google Scholar
• Park YB, Ha C-W, Lee C-H, et al. Cartilage regeneration in osteoarthritic patients by a composite of allogeneic umbilical cord blood-derived mesenchymal stem cells and hyaluronate hydrogel: results from a clinical trial for safety and proof-of-concept with 7 years of extended follow-up. Stem Cells Transl Med. 2017;6(2):613–621. doi:10.5966/sctm.2016-0157
   PubMed Web of Science ®Google Scholar
• Charoenviriyakul C, Takahashi Y, Morishita M, et al. Cell type-specific and common characteristics of exosomes derived from mouse cell lines: yield, physicochemical properties, and pharmacokinetics. Eur J Pharm Sci. 2017;96:316–322. doi:10.1016/j.ejps.2016.10.009
   PubMed Web of Science ®Google Scholar
• Mohan N, Mohanan PV, Sabareeswaran A, Nair P, et al. Chitosan-hyaluronic acid hydrogel for cartilage repair. Int J Biol Macromol. 2017;104(Pt B):1936–1945. doi:10.1016/j.ijbiomac.2017.03.142
   PubMed Web of Science ®Google Scholar
• Zhang K, Zhao X, Chen X, et al. Enhanced therapeutic effects of mesenchymal stem cell-derived exosomes with an injectable hydrogel for hindlimb ischemia treatment. ACS Appl Mater Interfaces. 2018;10(36):30081–30091. doi:10.1021/acsami.8b08449
   PubMed Web of Science ®Google Scholar
• Liu X, Yang Y, Li Y, et al. Integration of stem cell-derived exosomes with in situ hydrogel glue as a promising tissue patch for articular cartilage regeneration. Nanoscale. 2017;9(13):4430–4438. doi:10.1039/c7nr00352h
   PubMed Web of Science ®Google Scholar
• Li S, Stöckl S, Lukas C, et al. Curcumin-primed human BMSC-derived extracellular vesicles reverse IL-1β-induced catabolic responses of OA chondrocytes by upregulating miR-126-3p. Stem Cell Res Ther. 2021;12(1):252. doi:10.1186/s13287-021-02317-6
   PubMed Web of Science ®Google Scholar
• Malik TA. Inflammatory bowel disease: historical perspective, epidemiology, and risk factors. Surg Clin North Am. 2015;95(6):1105–1122. doi:10.1016/j.suc.2015.07.006
   PubMed Web of Science ®Google Scholar
• Crowley E, Muise A. Inflammatory bowel disease: what very early onset disease teaches us. Gastroenterol Clin North Am. 2018;47(4):755–772. doi:10.1016/j.gtc.2018.07.004
   PubMed Web of Science ®Google Scholar
• Shapiro JM, Subedi S, LeLeiko NS, et al. Inflammatory bowel disease. Pediatr Rev. 2016;37(8):337–347. doi:10.1542/pir.2015-0110
   PubMedGoogle Scholar
• Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014;20(1):91–99. doi:10.3748/wjg.v20.i1.91
   PubMed Web of Science ®Google Scholar
• Flynn S, Eisenstein S. Inflammatory bowel disease presentation and diagnosis. Surg Clin North Am. 2019;99(6):1051–1062. doi:10.1016/j.suc.2019.08.001
   PubMed Web of Science ®Google Scholar
• Sairenji T, Collins KL, Evans DV, et al. An update on inflammatory bowel disease. Prim Care. 2017;44(4):673–692. doi:10.1016/j.pop.2017.07.010
   PubMed Web of Science ®Google Scholar
• Lightner AL. Stem cell therapies for inflammatory bowel disease. Curr Gastroenterol Rep. 2019;21(4):16. doi:10.1007/s11894-019-0672-y
   PubMedGoogle Scholar
• Subramanian S, Geng H, Tan X-D, et al. Cell death of intestinal epithelial cells in intestinal diseases. Sheng Li Xue Bao. 2020;72(3):308–324.
   PubMedGoogle Scholar
• Blander JM. Death in the intestinal epithelium-basic biology and implications for inflammatory bowel disease. Febs j. 2016;283(14):2720–2730. doi:10.1111/febs.13771
   PubMed Web of Science ®Google Scholar
• Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat Rev Mol Cell Biol. 2014;15(1):19–33. doi:10.1038/nrm3721
   PubMed Web of Science ®Google Scholar
• Wang C, Li Y, Yang M, et al. Efficient differentiation of bone marrow mesenchymal stem cells into endothelial cells in vitro. Eur J Vasc Endovasc Surg. 2018;55(2):257–265. doi:10.1016/j.ejvs.2017.10.012
   PubMed Web of Science ®Google Scholar
• Deng X, Szabo S, Chen L, et al. New cell therapy using bone marrow-derived stem cells/endothelial progenitor cells to accelerate neovascularization in healing of experimental ulcerative colitis. Curr Pharm Des. 2011;17(16):1643–1651. doi:10.2174/138161211796197007
   PubMed Web of Science ®Google Scholar
• Deng H, Sun C, Sun Y, et al. Lipid, protein, and MicroRNA composition within mesenchymal stem cell-derived exosomes. Cell Reprogram. 2018;20(3):178–186. doi:10.1089/cell.2017.0047
   PubMed Web of Science ®Google Scholar
• Wu H, Fan H, Shou Z, et al. Extracellular vesicles containing miR-146a attenuate experimental colitis by targeting TRAF6 and IRAK1. Int Immunopharmacol. 2019;68:204–212. doi:10.1016/j.intimp.2018.12.043
   PubMed Web of Science ®Google Scholar
• Yang J, Zhou C-Z, Zhu R, et al. miR-200b-containing microvesicles attenuate experimental colitis associated intestinal fibrosis by inhibiting epithelial-mesenchymal transition. J Gastroenterol Hepatol. 2017;32(12):1966–1974. doi:10.1111/jgh.13797
   PubMed Web of Science ®Google Scholar
• Zhen Y, Zhang H. NLRP3 inflammasome and inflammatory bowel disease. Front Immunol. 2019;10:276. doi:10.3389/fimmu.2019.00276
   PubMed Web of Science ®Google Scholar
• Cai X, Zhang Z-Y, Yuan J-T, et al. hucMSC-derived exosomes attenuate colitis by regulating macrophage pyroptosis via the miR-378a-5p/NLRP3 axis. Stem Cell Res Ther. 2021;12(1):416. doi:10.1186/s13287-021-02492-6
   PubMed Web of Science ®Google Scholar
• He XW, He X-S, Lian L, et al. Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice. Dig Dis Sci. 2012;57(12):3136–3144. doi:10.1007/s10620-012-2290-5
   PubMed Web of Science ®Google Scholar
• Grégoire C, Lechanteur C, Briquet A, et al. Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases. Aliment Pharmacol Ther. 2017;45(2):205–221. doi:10.1111/apt.13864
   PubMed Web of Science ®Google Scholar
• Ciccocioppo R, Bernardo ME, Sgarella A, et al. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn’s disease. Gut. 2011;60(6):788–798. doi:10.1136/gut.2010.214841
   PubMed Web of Science ®Google Scholar
• Liou IW. Management of end-stage liver disease. Med Clin North Am. 2014;98(1):119–152. doi:10.1016/j.mcna.2013.09.006
   PubMed Web of Science ®Google Scholar
• Marcellin P, Kutala BK. Liver diseases: a major, neglected global public health problem requiring urgent actions and large-scale screening. Liver Int. 2018;38(Suppl 1):2–6. doi:10.1111/liv.13682
   PubMed Web of Science ®Google Scholar
• Hu C, Li L. In vitro culture of isolated primary hepatocytes and stem cell-derived hepatocyte-like cells for liver regeneration. Protein Cell. 2015;6(8):562–574. doi:10.1007/s13238-015-0180-2
   PubMed Web of Science ®Google Scholar
• Fyfe B, Zaldana F, Liu C, et al. The pathology of acute liver failure. Clin Liver Dis. 2018;22(2):257–268. doi:10.1016/j.cld.2018.01.003
   PubMed Web of Science ®Google Scholar
• Koyama Y, Brenner DA. Liver inflammation and fibrosis. J Clin Invest. 2017;127(1):55–64. doi:10.1172/jci88881
   PubMed Web of Science ®Google Scholar
• Lee CA, Sinha S, Fitzpatrick E, et al. Hepatocyte transplantation and advancements in alternative cell sources for liver-based regenerative medicine. J Mol Med (Berl). 2018;96(6):469–481. doi:10.1007/s00109-018-1638-5
   PubMed Web of Science ®Google Scholar
• Liu WH, Song F-Q, Ren L-N, et al. The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases. J Cell Mol Med. 2015;19(3):511–520. doi:10.1111/jcmm.12482
   PubMed Web of Science ®Google Scholar
• Afshari A, Shamdani S, Uzan G, et al. Different approaches for transformation of mesenchymal stem cells into hepatocyte-like cells. Stem Cell Res Ther. 2020;11(1):54. doi:10.1186/s13287-020-1555-8
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhao Y, Zhang L, et al. The application of mesenchymal stem cells in the treatment of liver diseases: mechanism, efficacy, and safety issues. Front Med. 2021;8:655268. doi:10.3389/fmed.2021.655268
   Web of Science ®Google Scholar
• Wu XB, Tao R. Hepatocyte differentiation of mesenchymal stem cells. Hepatobiliary Pancreat Dis Int. 2012;11(4):360–371. doi:10.1016/s1499-3872(12)60193-3
   PubMed Web of Science ®Google Scholar
• Chen L, Lu F-B, Chen D-Z, et al. BMSCs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis. Mol Immunol. 2018;93:38–46. doi:10.1016/j.molimm.2017.11.008
   PubMed Web of Science ®Google Scholar
• Liu Y, Lou G, Li A, et al. AMSC-derived exosomes alleviate lipopolysaccharide/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP/NLRP3 inflammasome activation in macrophages. EBioMedicine. 2018;36:140–150. doi:10.1016/j.ebiom.2018.08.054
   PubMed Web of Science ®Google Scholar
• Lin B-L, Chen J-F, Qiu W-H, et al. Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial. Hepatology. 2017;66(1):209–219. doi:10.1002/hep.29189
   PubMed Web of Science ®Google Scholar
• Li Y-H, Xu Y, Wu H-M, et al. Umbilical cord-derived mesenchymal stem cell transplantation in Hepatitis B virus related acute-on-chronic liver failure treated with plasma exchange and entecavir: a 24-month prospective study. Stem Cell Rev Rep. 2016;12(6):645–653. doi:10.1007/s12015-016-9683-3
   PubMed Web of Science ®Google Scholar
• Schacher FC, Martins Pezzi da Silva A, Silla LMDR, et al. Bone marrow mesenchymal stem cells in acute-on-chronic liver failure Grades 2 and 3: a Phase I-II Randomized Clinical Trial. Can J Gastroenterol Hepatol. 2021;2021:3662776. doi:10.1155/2021/3662776
   PubMed Web of Science ®Google Scholar
• Shi M, Zhang Z, Xu R, et al. Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med. 2012;1(10):725–731. doi:10.5966/sctm.2012-0034
   PubMed Web of Science ®Google Scholar
• Owen A, Newsome PN. Mesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?. Am J Physiol Gastrointest Liver Physiol. 2015;309(10):G791–800. doi:10.1152/ajpgi.00036.2015
   PubMed Web of Science ®Google Scholar
• Kawakubo K, Ohnishi S, Kuwatani M, Sakamoto N, et al. Mesenchymal stem cell therapy for acute and chronic pancreatitis. J Gastroenterol. 2018;53(1):1–5. doi:10.1007/s00535-017-1363-9
   PubMed Web of Science ®Google Scholar
• Goodman RR, Jong MK, Davies JE, et al. Concise review: the challenges and opportunities of employing mesenchymal stromal cells in the treatment of acute pancreatitis. Biotechnol Adv. 2020;42:107338. doi:10.1016/j.biotechadv.2019.01.005
   PubMed Web of Science ®Google Scholar
• Ahmed SM, Morsi M, Ghoneim NI, et al. Mesenchymal stromal cell therapy for pancreatitis: a systematic review. Oxid Med Cell Longev. 2018;2018:3250864. doi:10.1155/2018/3250864
   PubMed Web of Science ®Google Scholar
• Ren S, Pan L, Yang L, et al. miR-29a-3p transferred by mesenchymal stem cells-derived extracellular vesicles protects against myocardial injury after severe acute pancreatitis. Life Sci. 2021;272:119189. doi:10.1016/j.lfs.2021.119189
   PubMed Web of Science ®Google Scholar
• Yin G, Hu G, Wan R, et al. Role of microvesicles from bone marrow mesenchymal stem cells in acute pancreatitis. Pancreas. 2016;45(9):1282–1293. doi:10.1097/mpa.0000000000000694
   PubMed Web of Science ®Google Scholar
• Kawakubo K, Ohnishi S, Fujita H, et al. Effect of fetal membrane-derived mesenchymal stem cell transplantation in rats with acute and chronic pancreatitis. Pancreas. 2016;45(5):707–713. doi:10.1097/mpa.0000000000000541
   PubMed Web of Science ®Google Scholar
• Song G, Ma Z, Liu D, et al. Bone marrow-derived mesenchymal stem cells ameliorate severe acute pancreatitis by inhibiting necroptosis in rats. Mol Cell Biochem. 2019;459(1–2):7–19. doi:10.1007/s11010-019-03546-3
   PubMed Web of Science ®Google Scholar
• Vaquer-Alicea J, Diamond MI. Propagation of protein aggregation in neurodegenerative diseases. Annu Rev Biochem. 2019;88:785–810. doi:10.1146/annurev-biochem-061516-045049
   PubMed Web of Science ®Google Scholar
• Chen WW, Zhang X, Huang W-J, et al. Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Rep. 2016;13(4):3391–3396. doi:10.3892/mmr.2016.4948
   PubMed Web of Science ®Google Scholar
• Bonafede R, Mariotti R. ALS pathogenesis and therapeutic approaches: the role of mesenchymal stem cells and extracellular vesicles. Front Cell Neurosci. 2017;11:80. doi:10.3389/fncel.2017.00080
   PubMed Web of Science ®Google Scholar
• Zriek F, Di Battista JA, Alaaeddine N, et al. Mesenchymal stromal cell secretome: immunomodulation, tissue repair and effects on neurodegenerative conditions. Curr Stem Cell Res Ther. 2021;16(6):656–669. doi:10.2174/1574888x16666210202145639
   PubMed Web of Science ®Google Scholar
• Joo HS, Suh JH, Lee HJ, Bang ES, Lee JM, et al. Current knowledge and future perspectives on mesenchymal stem cell-derived exosomes as a new therapeutic agent. Int J Mol Sci. 2020;21(3):727. doi:10.3390/ijms21030727
   PubMed Web of Science ®Google Scholar
• Chen X, Wang S, Cao W, et al. Mesenchymal stem cell-mediated immunomodulation in cell therapy of neurodegenerative diseases. Cell Immunol. 2018;326:8–14. doi:10.1016/j.cellimm.2017.06.006
   PubMed Web of Science ®Google Scholar
• Staff NP, Jones DT, Singer W, et al. Mesenchymal stromal cell therapies for neurodegenerative diseases. Mayo Clin Proc. 2019;94(5):892–905. doi:10.1016/j.mayocp.2019.01.001
   PubMed Web of Science ®Google Scholar
• Lee PH, Kim JW, Bang OY, et al. Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Clin Pharmacol Ther. 2008;83(5):723–730. doi:10.1038/sj.clpt.6100386
   PubMed Web of Science ®Google Scholar
• Venkataramana NK, Pal R, Rao SAV, et al. Bilateral transplantation of allogenic adult human bone marrow-derived mesenchymal stem cells into the subventricular zone of Parkinson’s disease: a pilot clinical study. Stem Cells Int. 2012;2012:931902. doi:10.1155/2012/931902
   PubMed Web of Science ®Google Scholar
• Li JJ, Yi S, Wei L, et al. Ocular microbiota and intraocular inflammation. Front Immunol. 2020;11:609765. doi:10.3389/fimmu.2020.609765
   PubMed Web of Science ®Google Scholar
• Albini TA, Davis JL. Ocular immunity and inflammation. Dev Ophthalmol. 2016;55:38–45. doi:10.1159/000431131
   PubMedGoogle Scholar
• Lee HJ, Ko JH, Jeong HJ, et al. Mesenchymal stem/stromal cells protect against autoimmunity via CCL2-dependent recruitment of myeloid-derived suppressor cells. J Immunol. 2015;194(8):3634–3645. doi:10.4049/jimmunol.1402139
   PubMed Web of Science ®Google Scholar
• Harrell CR, Simovic Markovic B, Fellabaum C, et al. Therapeutic potential of mesenchymal stem cell-derived exosomes in the treatment of eye diseases. Adv Exp Med Biol. 2018;1089:47–57. doi:10.1007/5584_2018_219
   PubMed Web of Science ®Google Scholar
• Rajool Dezfuly A, Safaee A, Salehi H, et al. Therapeutic effects of mesenchymal stem cells-derived extracellular vesicles’ miRNAs on retinal regeneration: a review. Stem Cell Res Ther. 2021;12(1):530. doi:10.1186/s13287-021-02588-z
   PubMed Web of Science ®Google Scholar
• Timin AS, Peltek OO, Zyuzin MV, et al. Safe and effective delivery of antitumor drug using mesenchymal stem cells impregnated with submicron carriers. ACS Appl Mater Interfaces. 2019;11(14):13091–13104. doi:10.1021/acsami.8b22685
   PubMed Web of Science ®Google Scholar
• Elahi FM, Farwell DG, Nolta JA, et al. Preclinical translation of exosomes derived from mesenchymal stem/stromal cells. Stem Cells. 2020;38(1):15–21. doi:10.1002/stem.3061
   PubMed Web of Science ®Google Scholar
• Samanta S, Rajasingh S, Drosos N, et al. Exosomes: new molecular targets of diseases. Acta Pharmacol Sin. 2018;39(4):501–513. doi:10.1038/aps.2017.162
   PubMed Web of Science ®Google Scholar
• Toh WS, Lai RC, Zhang B, et al. MSC exosome works through a protein-based mechanism of action. Biochem Soc Trans. 2018;46(4):843–853. doi:10.1042/bst20180079
   PubMed Web of Science ®Google Scholar
• Campbell CR, Berman AE, Weintraub NL, et al. Electrical stimulation to optimize cardioprotective exosomes from cardiac stem cells. Med Hypotheses. 2016;88:6–9. doi:10.1016/j.mehy.2015.12.022
   PubMed Web of Science ®Google Scholar
• Liu H, Deng S, Han L, et al. Mesenchymal stem cells, exosomes and exosome-mimics as smart drug carriers for targeted cancer therapy. Colloids Surf B Biointerfaces. 2021;209(Pt 1):112163. doi:10.1016/j.colsurfb.2021.112163
   PubMed Web of Science ®Google Scholar
• Chen HY, Deng J, Wang Y, et al. Hybrid cell membrane-coated nanoparticles: a multifunctional biomimetic platform for cancer diagnosis and therapy. Acta Biomater. 2020;112:1–13. doi:10.1016/j.actbio.2020.05.028
   PubMed Web of Science ®Google Scholar
• Himbert S, Blacker MJ, Kihm A, et al. Hybrid erythrocyte liposomes: functionalized red blood cell membranes for molecule encapsulation. Adv Biosyst. 2020;4(3):e1900185. doi:10.1002/adbi.201900185
   PubMed Web of Science ®Google Scholar
• Patil SM, Sawant SS, Kunda NK, et al. Exosomes as drug delivery systems: a brief overview and progress update. Eur J Pharm Biopharm. 2020;154:259–269. doi:10.1016/j.ejpb.2020.07.026
   PubMed Web of Science ®Google Scholar
• Muslimov AR, Timin AS, Bichaykina VR, et al. Biomimetic drug delivery platforms based on mesenchymal stem cells impregnated with light-responsive submicron sized carriers. Biomater Sci. 2020;8(4):1137–1147. doi:10.1039/c9bm00926d
   PubMed Web of Science ®Google Scholar
• Wang J, Chen P, Dong Y, et al. Designer exosomes enabling tumor targeted efficient chemo/gene/photothermal therapy. Biomaterials. 2021;276:121056. doi:10.1016/j.biomaterials.2021.121056
   PubMed Web of Science ®Google Scholar
• Timin AS, Litvak MM, Gorin DA, et al. Cell-based drug delivery and use of nano-and microcarriers for cell functionalization. Adv Healthc Mater. 2018;7(3). doi:10.1002/adhm.201700818
   PubMed Web of Science ®Google Scholar